Vlado Perkovic's guest appearances

Vlado Perkovic

Nursing Review

Aged Care Insite

Medicine Matters diabetes

Robert Booy

Kathy Finlayson

Anthony Tuckett

Keith Hill

Ekta Agarwal

Belinda Goodenough

Chanaka Wijeratne

Ged Kearney

Marianne Wallis

Linda Raymond

Maree Bernoth

Ian McGrath

Brett Holmes

Jaklin Eliott

Karen Booth

OwlTail

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice. Find more on Medicine Matters diabetes This content was originally published on Medicine Matters diabetes (https://diabetes.medicinematters.com) on April 15, 2019.

Lead investigator Vlado Perkovic talks about the main findings from the CREDENCE trial – demonstrating that canagliflozin is associated with a reduced risk for kidney failure and cardiovascular events in people with type 2 diabetes and chronic kidney disease – and discusses how these results will impact clinical practice. <a href="http://bit.ly/Perkovic-CREDENCE-trial-comment" rel="noopener nofollow" target="_blank">Find more on Medicine Matters diabetes</a> This content was originally published on Medicine Matters diabetes (<a href="https://diabetes.medicinematters.com" rel="nofollow" target="_blank">https://diabetes.medicinematters.com</a>) on April 15, 2019.

Researcher comment: The CREDENCE trial (with Vlado Perkovic)

Professor Vlado Perkovic, executive director of The George Institute for Global Health on the report, Putting the consumer first: Creating a consumer-centred health system for a 21st Century Australia.

Vlado Perkovic, executive director of The George Institute for Global Health